View Older Stories View More Recent Stories

Dec 4, 2023 07:00AM Vestar Capital Partners Completes Sale of Edward Don & Company to Sysco
Dec 4, 2023 06:10AM SharkNinja (SN) to offer 5.6M shares for holders
Dec 4, 2023 06:09AM SharkNinja Announces Launch of Secondary Offering of Ordinary Shares
Dec 1, 2023 04:00PM Verve Therapeutics Announces Closing of Public Offering of Common Stock, Full Exercise by Underwriters of Option to Purchase Additional Shares and Closing of Concurrent Private Placement
Dec 1, 2023 12:00PM Payoneer to Participate in a Virtual Fireside Chat with William Blair on December 12, 2023
Nov 28, 2023 10:37PM Verve Therapeutics Announces Pricing of Public Offering of Common Stock and Concurrent Private Placement
Nov 28, 2023 04:03PM Verve Therapeutics (VERV) Announces Proposed Public Offering of Common Stock and Concurrent Private Placement
Nov 28, 2023 04:01PM Verve Therapeutics Announces Proposed Public Offering of Common Stock and Concurrent Private Placement
Nov 28, 2023 09:51AM Holding(s) in Company
Nov 28, 2023 09:00AM Presenting Companies Announced for the 2024 ICR Conference
Nov 27, 2023 08:30AM NEUBERGER BERMAN CAPITAL SOLUTIONS LEADS ACQUISITION OF MINORITY STAKE IN COLIBRI GROUP
Nov 24, 2023 11:11AM Holding(s) in Company
Nov 24, 2023 08:53AM Zambia bondholder deal flop prompts calls for rethink of debt reworks
Nov 22, 2023 08:20AM Analysts see downside risk for this AI-hyped stock
Nov 22, 2023 08:09AM William Blair Reiterates Underperform Rating on Palantir Technologies Inc. (PLTR)
Nov 21, 2023 12:05PM Form NPORT-P WILLIAM BLAIR FUNDS For: Sep 30
Nov 21, 2023 12:05PM Form NPORT-P WILLIAM BLAIR FUNDS For: Sep 30
Nov 21, 2023 12:05PM Form NPORT-P WILLIAM BLAIR FUNDS For: Sep 30
Nov 21, 2023 12:05PM Form NPORT-P WILLIAM BLAIR FUNDS For: Sep 30
Nov 21, 2023 12:05PM Form NPORT-P WILLIAM BLAIR FUNDS For: Sep 30
Nov 21, 2023 12:05PM Form NPORT-P WILLIAM BLAIR FUNDS For: Sep 30
Nov 21, 2023 12:05PM Form NPORT-P WILLIAM BLAIR FUNDS For: Sep 30
Nov 21, 2023 12:05PM Form NPORT-P WILLIAM BLAIR FUNDS For: Sep 30
Nov 21, 2023 12:05PM Form NPORT-P WILLIAM BLAIR FUNDS For: Sep 30
Nov 21, 2023 12:05PM Form NPORT-P WILLIAM BLAIR FUNDS For: Sep 30
Nov 21, 2023 12:05PM Form NPORT-P WILLIAM BLAIR FUNDS For: Sep 30
Nov 21, 2023 12:05PM Form NPORT-P WILLIAM BLAIR FUNDS For: Sep 30
Nov 21, 2023 12:05PM Form NPORT-P WILLIAM BLAIR FUNDS For: Sep 30
Nov 21, 2023 12:05PM Form NPORT-P WILLIAM BLAIR FUNDS For: Sep 30
Nov 21, 2023 12:05PM Form NPORT-P WILLIAM BLAIR FUNDS For: Sep 30
Nov 21, 2023 12:05PM Form NPORT-P WILLIAM BLAIR FUNDS For: Sep 30
Nov 21, 2023 12:05PM Form NPORT-P WILLIAM BLAIR FUNDS For: Sep 30
Nov 21, 2023 12:05PM Form NPORT-P WILLIAM BLAIR FUNDS For: Sep 30
Nov 21, 2023 12:05PM Form NPORT-P WILLIAM BLAIR FUNDS For: Sep 30
Nov 21, 2023 10:33AM Curi Capital to Merge with RMB Capital
Nov 21, 2023 06:30AM Levine Leichtman Capital Partners Sells Therapeutic Research Center
Nov 20, 2023 04:30PM Colibri Group Announces Strategic Acquisition of TRC Healthcare
Nov 20, 2023 07:49AM Bristol-Myers Squibb (BMY) Weakness Tied to News Bayer Halted OCEANIC-AF Study
Nov 20, 2023 07:30AM Zevra Therapeutics Completes Acquisition of Acer Therapeutics in its Journey to Become a Leading Rare Disease Company
Nov 16, 2023 09:33AM MN-based Clean Hair Care Brand Odele Takes on Minority Investment from Stride Consumer Partners
Nov 16, 2023 04:54AM Augmedix (AUGX) Prices Upsized 6.25M Share Offering at $4/sh
Nov 16, 2023 12:15AM Augmedix Announces Pricing of Upsized Public Offering of 6,250,000 Shares of Common Stock
Nov 15, 2023 04:03PM Augmedix, Inc (AUGX) Announces Proposed 5.5M Share Offering
Nov 15, 2023 04:02PM Augmedix Announces Proposed Public Offering of 5,500,000 Shares of Common Stock
Nov 15, 2023 09:09AM William Blair Starts Reneo Pharmaceuticals (RPHM) at Outperform, 'Mavodelpar Showing Promise'
Nov 15, 2023 07:01AM LENZ Therapeutics and Graphite Bio (GRPH) Announce Merger Agreement
Nov 15, 2023 07:00AM LENZ Therapeutics and Graphite Bio Announce Merger Agreement
Nov 13, 2023 02:04PM BGL Welcomes Brandon Dobell as Managing Director within Services
Nov 13, 2023 10:12AM H.I.G. Capital Completes Sale of Tastes on the Fly
Nov 13, 2023 08:36AM William Blair Downgrades Aclaris Therapeutis (ACRS) to Market Perform
View More Recent Stories View Older Stories